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Abstract
Purpose Osteoarthritis (OA) is an age-related joint disease
that is characterised by the degeneration of articular
chondrocytes. Ginsenosides, the most important pharmacolog-
ical ingredients of ginseng, have been proven to provide effec-
tive therapy for neurodegenerative diseases and can inhibit cell
apoptosis. We investigated whether ginsenoside Rb1 can mod-
ulate inflammation and apoptosis in human chondrocytes.
Methods Chondrocytes were isolated from OA patients under-
going total knee replacement surgery. Apoptosis was assessed
by TUNEL (terminal deoxyribonucleotide transferasemediated
dUTP nick end-labelling)-positive staining. Levels of PGE2
and NO2- were detected by ELISA. Gene expression levels
were measured for type II collagen (Col2A1), aggrecan,MMP-
13, COX-2, iNOS, caspase-3, and PARP.
Results The results showed that TUNEL-positive staining
chondrocytes were decreased by Rb1 compared with IL-
1β. Both 10 or 100 μg/ml Rb1 inhibited the effect of IL-
1β on chondrocytes by decreasing levels of PGE2, NO2-,
MMP-13,COX-2, iNOS, caspase-3 and PARP and increasing
aggrecan and Col2A1 gene expression levels, to block IL-
1β-induced cell inflammation and apoptosis.
Conclusions The results suggest that Rb1 possesses poten-
tial anti-inflammatory and anti-apoptotic properties in hu-
man chondrocytes, possibly by binding to oestrogen recep-
tors to exert its pharmacological effects.
Introduction
Osteoarthritis (OA) is an age-related joint disease that is
characterised by the degeneration of articular chondrocytes
[1]. Chondrocytes are only one cell type which are responsible
for the maintenance of the extracellular matrix (ECM).
Interleukin-1 beta (IL-1β) causes inflammation of articular
cartilage, stimulates the production of matrix metalloprotein-
ases (MMPs), cyclo-oxygenase-2 (COX-2) and prostaglandin
E2 (PGE2), and is therefore a target for therapeutic strategies
[2, 3]. These inflammatory cytokines can further inhibit the
synthesis of the main constituents of the ECM, type II collagen
(Col2A1) and aggrecan (ACAN), and can disrupt the balance
of metabolism in articular cartilage. Apoptosis is thought to
have a pivotal role in human and animal OA [4]. It has been
reported that apoptosis of chondrocytes can be induced by
different agents, such as caspase-3 and inducible nitric oxide
synthase (iNOS) [5, 6]. During apoptotic cell death caspases
activate the cleavage of the DNA repair enzyme poly(ADP-
ribose) polymerase (PARP) in chondrocytes.
Ginsenosides, the most important pharmacological ingredi-
ents of ginseng, have been proven to provide effective therapy
for neurodegenerative diseases and can inhibit cell apoptosis.
To date, more than 40 different ginsenosides have been iden-
tified and isolated from the root of ginseng [7]. Ginsenosides
are generally divided into two groups, panaxadiols and
panaxatriols, based on the chemical structure [8]. Panaxadiols
include compounds called ginsenoside Rb1 (Rb1), which is the
most abundant among more than 40 ginsenosides. A previous
Wendan Cheng and Dongying Wu are co-first authors.
W. Cheng :Q. Zuo :W. Fan (*)
Department of Orthopedics, The First Affiliated Hospital




Lu’an People’s Hospital Affiliated to Anhui Medical University,
Lu’an 237000, China
D. Wu
Department of Orthopedics, The Affiliated Hospital of Xuzhou
Medical College, Xuzhou 221006, China
Z. Wang
Department of Orthopedics, The People’s Hospital of Luhe,
Luhe 211500, China
International Orthopaedics (SICOT) (2013) 37:2065–2070
DOI 10.1007/s00264-013-1990-6
study has shown that Rb1 can exert a suppressive effect
on local inflammation in rats with cerebral ischemia [9].
Furthermore, Rb1 protects PC12 cells from apoptosis
through stimulation of the oestrogen receptor [10].
However, no data yet has been reported concerning the effect
of Rb1 on apoptosis and inflammation in chondrocytes or its
therapeutic role in OA.
In this study we investigated whether Rb1 is able to
inhibit apoptosis and inflammatory responses in OA by
establishing an in vitro model in human chondrocytes.
Materials and methods
Materials
Rb1 was purchased from the National Institutes for Food and
Drug Control (Beijing, China). Recombinant human IL-1βwas
provided by R&D Systems (St. Paulo, MN, USA). High glu-
cose diluted Dulbecco’s modified Eagle’s medium (DMEM),
foetal bovine serum (FBS), 6-dianidino-2-phenylindole
dihydrochloride (DAPI) and penicillin/streptomycin were
obtained from Gibco (NY, USA). In Situ Cell Apoptosis
Detection kits were purchased from Roche Diagnostics (East
Sussex, UK).
Cell culture
All experiments were approved by the Ethical Commit-
tee of Nanjing Medical University. Articular cartilage
samples were obtained from OA patients undergoing
total knee replacement surgery. All patients were diag-
nosed using the criteria of the American College of
Rheumatology. Harvested cartilage was minced into small
pieces and incubated in a trypsin-containing solution for two
hours at 37 °C. The pieces were then washed with phosphate-
buffered saline (PBS) and incubated at 37 °C overnight in
0.2 % collagenase. After digestion, the chondrocytes were
collected and cultured in DMEM/F12 medium containing
10 % FBS and 100U/ml of penicillin–streptomycin at 37 °C
in a humidified 5 % CO2 atmosphere. Cells were used at
passage 0 or 1 to avoid dedifferentiation.
Experimental design
First-generation human chondrocytes were cultured in
DMEM medium without serum and with 2 % serum-
free bovine serum albumin (BSA) for 24 hours after
washing three times with PBS to prevent the influence
of other cytokines. Cells were treated with 10 ng/ml IL-
1β and Rb1 at 1, 10 and 100 μg/ml. A positive control
group consisted of cells treated with 10 ng/ml IL-1β
alone. A negative control group was untreated except
for a change in the medium. Cells were harvested after
incubation for 24 hours.
Cell apoptosis
According to the manufacturer's instructions, terminal
deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate-biotin nick end-labelling (TUNEL)was performed
to detect cell apoptosis. Images were randomly selected from
two sections of each specimen and the stained cells were
counted under 400 magnification. Chondrocytes were
stained with DAPI at 37 °C for 30 minutes Apoptotic
chondrocytes were recognised with dual TUNEL and
DAPI staining. For each group in experiments, three images
were randomly selected using an inverted fluorescence
microscope.
Quantification of nitrite (NO2
−) and PGE2 concentrations
ELISA kits were used to measure NO2
− and PGE2
levels according to the manufacturer’s protocol. NO2
−
concentrations were determined using the respective
standard curves and normalised against the control
concentration.
RNA extraction and quantitative real-time polymerase chain
reaction (PCR)
Gene expression levels of Col2A1, ACAN, MMP-13, COX-2,
iNOS, caspase-3, PARP and β-actin of human chondrocytes
induced by IL-1β were determined using real-time PCR.
TRIzol and chloroform reagents were used to extract total
RNA according to the manufacturer’s instructions. RNA con-
centrations were measured using a spectrophotometer; sam-
ples with values of 1.7–2.0 were used. Complimentary DNA
(cDNA) was synthesised from RNA using reverse transcrip-
tase and a PrimeScript RT reagent kit (Fermentas, Lithuania).
Real-time PCR was carried out by combining 2 μl of cDNA
with reagents from the SYBR Premix Ex Taq II to give a total
volume of 20μl. The generation of specific PCR products was
confirmed by melting-curve analysis; mRNA encoding β-
actin served as an internal control. Gene expression data for
the proteins of interest were standardised against β-actin. The
primers (TaKaRa, Japan) used are shown in Table 1.
Analysis
Results are expressed as mean ± standard deviation (SD). All
analyses were performed using SPSS version 16.0 software
(SPSS Inc., Chicago, IL, USA). For multiple comparisons,
one-way analysis of variance was used depending on the
experiment design. A p value of <0.05 was considered
statistically significant.
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Results
Effect of Rb1 on chondrocyte apoptosis
TUNEL staining confirmed the effect of Rb1 on chondrocyte
apoptosis (Fig. 1). Percentage of TUNEL positive cells after
48 hours of IL-1β exposure was 37.30 %, which was higher
than control (p<0.05). When the chondrocytes were co-
cultured with 10 μg/ml of IL-1β and Rb1 the percentage of
TUNEL positive cells (20.33 %) was lower than the IL-1β
group (p<0.05).
Effects of Rb1 on IL-1β-induced Col2A1 and AGAN gene
expression
Quantitative real-time PCR was used to analyse gene expres-
sion. Stimulation with IL-1β (10 ng/ml) led to a 2.9-fold
decrease of Col2A1 and ACAN gene expression compared to
the negative control (p<0.05) (Fig. 2). Theywere increased 1.7-
and 2.3-fold (p<0.05) after co-treatment with 10 μg/ml Rb1,
and 2.4- and 2.0-fold (p<0.05) after co-treatment with 100-
μg/ml Rb1. However, no effect was found with 1 μg/ml Rb1
(p>0.05). The effect of Rb1 was found to be dose-dependent.
Rb1 inhibited MMP-13 and COX-2 gene expression
and IL-1β-induced PGE2 production
IL-1β stimulation (10 ng/ml) for 24 hours led to a 27.2-fold
increase in MMP-13 gene expression compared to the nega-
tive control (p<0.05) (Fig. 3). On addition of 10 or 100μg/ml
Rb1,MMP-13 gene expression decreased by 4.8- or 4.4-fold,
respectively (p<0.05). Stimulation with IL-1β (10 ng/ml)
led to a 19.8-fold increase in COX-2 gene expression. After
co-treatment with 10 or 100 μg/ml Rb1, COX-2 gene
expression levels were reduced 3.0- or 2.5-fold (p<0.05).
However, no effect was found at 1 μg/ml Rb1.
Levels of PGE2 in the supernatant were assessed using
ELISA. As shown in Fig. 3, stimulation of human
chondrocytes with IL-1β produced a two-fold increase in
PGE2 compared with the control (p<0.05). Interestingly,
chondrocytes stimulated with IL-1β in the presence of 10
or 100 μg/ml Rb1 led to 3-fold decrease in PGE2 (p<0.05).
Rb1 inhibited iNOS, caspase-3 and PARP gene expression
and IL-1β-induced nitric oxide (NO) production
Stimulation with IL-1β (10 ng/ml) for 24 hours led to a
111.2-fold increase in iNOS gene expression as well as a
six-fold increase in NO production in the supernatant
(p<0.05) (Fig. 4). At a concentration of 1 μg/ml, Rb1 slight-
ly decreased the gene expression of iNOS and production of
NO (p>0.05), whereas at a concentration of 10 μg/ml the
gene expression of iNOS and production of NO decreased by
6.5- and 2.6-fold, respectively (p<0.05). Rb1 at a concen-
tration of 100 μg/ml decreased the gene expression of iNOS
and production of NO 6.5- and 4.0-fold, respectively
(p<0.05). Stimulation with IL-1β (10 ng/ml) led to a 5.4-
fold increase in caspase-3 and a 3.0-fold increase in PARP
(p<0.05) (Fig. 4). They were decreased 2.3- and 2.7-fold
after co-treatment with 10 μg/ml Rb1 and 1.9- and 2.0-fold
after co-treatment with 100 μg/ml Rb1 (p<0.05). However,
no effect was found at 1 μg/ml Rb1 (p>0.05).
Discussion
Ginsenoside Rb1 is one of the richest subtypes in quantity
among 30 ginsenosides, which exert multiple biological
Table 1 Sequences of primers
for the quantitative RT-PCR
experiments
Gene Sense Sequence 5′→ 3′ Size(pb)
β-actin F GCAGAAGGAGATCACTGCCCT 136
R GCTGATCCACATCTGCTGGAA
Caspase-3 F CATGGAAGCGAATCAATGGACT 139
R CTGTACCAGACCGAGATGTCA
iNOS F ACCAGTACGTTTGGCAATGG 70
R TCAGCATGAAGAGCGATTTCT
PARP F TCTTTGATGTGGAAAGTATGAAGAA 64
R GGCATCTTCTGAAGGTCGAT
MMP-13 F TCCTGATGTGGGTGAATACAATG 184
R GCCATCGTGAAGTCTGGTAAAAT
ACAN F GTGCCTATCAGGACAAGGTCT 167
R GATGCCTTTCACCACGACTTC
COX-2 F CTTACAATGCTGACTATGGCTAC 242
R AAACTGATGCGTGAAGTGCTG
Col2A1 F TTCAGCTATGGAGATGACAATC 472
R AGAGTCCTAGAGTGACTGAG
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actions including anti-inflammatory, anti-apoptosis, and
neuroprotective activities [10, 11]. In this paper, our
findings suggest that Rb1 can inhibit the production of
inflammatory agents such as MMP-13, COX-2, PGE2,
iNOS and NO, and decrease Col2A1 and ACAN degra-
da t ion induced by IL-1β i n human a r t i cu l a r
chondrocytes. Real-time PCR results showed that Rb1
inhibited the gene expression of the apoptotic bio-
markers, caspase-3 and PARP, in chondrocytes.
IL-1β leads to the production and accumulation of high
levels of pro-inflammatory cytokines in OA synovial cells and
chondrocytes. These trigger the production of additional pro-
inflammatory cytokines which induce genes encoding COX-2
and matrix-degrading enzymes such as MMPs. Furthermore,
Fig. 2 Effect of Rb1 on IL-1β-
induced Col2A1 and AGAN
gene expression. The normalised
gene expression levels are
expressed as ratios of the copy
number of the mRNA and that of
β-actin cDNA. Data were
obtained from three independent
experiments and are presented as
the mean ± SD. ★★p<0.05 vs.
the control. ★p<0.05
Fig. 1 Effect of Rb1 on
chondrocyte apoptosis. All data
are mean ± SD. ★★p<0.05 vs.
the IL group. ★p<0.05 vs. the
control
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COX-2 converts arachidonic acid into PGE2, which together
with COX-2, sensitise peripheral receptors and cause pain [12,
13]. In the present study, we found that elevated COX-2 and
MMP-13 gene expression and PGE2 production in IL-1β-
induced cells was suppressed by the addition of Rb1. This
suggests that Rb1 may act as an anti-inflammatory similar to
NSAIDs, which have been shown to ameliorate OA symptoms
by inhibiting the expression of COX-2 and PGE2 [14].
Fig. 3 Effect of Rb1 on IL-1β-
induced MMP-13 and COX-2
gene expression and IL-1β-
induced PGE2 production. The
normalised gene expression
levels are expressed as ratios of
the copy number of the mRNA
and that of β-actin cDNA. Data
were obtained from three
independent experiments and are
presented as the mean ± SD.
★★p<0.05 vs. the control.
★p<0.05 vs. the IL-1β group
Fig. 4 Effect of Rb1 on IL-1β-
induced iNOS caspase-3 and
PARP gene expression and IL-
1β-induced NO production. The
normalized gene expression
levels are expressed as ratios of
the copy number of the mRNA
and that of β-actin cDNA.
Culture media were analysed for
NO2- concentration. All data
shown were the mean ± SD of
NO2- concentration as a
percentage of the control.
★★p<0.05 vs. the control.
★p<0.05 vs. the IL-1β
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It is widely accepted that increased IL-1β levels can
trigger apoptosis in chondrocytes, which leads to further
degenerative changes in cartilage. Of the 12 caspases in
mammals, caspase-3 is a crucial biomarker of apoptosis that
also acts as an apoptotic executor [15]. PARP, a downstream
target of caspase-3, is a nuclear enzyme normally involved in
DNA repair, but extensive activation of PARP promotes cell
death [16]. We found that levels of mRNAs encoding
caspase-3 and PARP in human chondrocytes treated with
IL-1β were upregulated, whereas co-treatment with Rb1
downregulated the expression levels of these genes in IL-
1β-stimulated chondrocytes. Our findings indicate that Rb1
could inhibit chondrocyte apoptosis induced by IL-1β.
Evidence has confirmed the existence of two oestrogen
receptors (ERs) in the articular cartilage, indicating that the
cartilage can respond to estrogen [17]. Oestrogen has a protec-
tive effect in OA [18]. Rb1 could exert an oestrogen-like effect
by binding to ERs [19]. Hashimoto et al. found that ginsenoside
Rb1 protects PC12 cells from caspase-3-dependent apoptosis
through stimulation of oestrogen receptors [10]. We suggest
that Rb1 acts in a similar way to oestrogen in treating OA.
In conclusion, our work shows that Rb1 possesses poten-
tial anti-inflammatory and anti-apoptotic properties in hu-
man chondrocytes, possibly through binding to ERs to exert
pharmacological effects. These findings suggest that Rb1
may help protect against the degeneration of cartilage in
patients with OA.
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